Cancer treatment
Everolimus and your teeth
Generic name: Everolimus · Class: mTOR inhibitor
Everolimus is an mTOR inhibitor used for breast cancer, kidney cancer, neuroendocrine tumors, and as an immunosuppressant after some transplants.
Everolimus is notorious for causing oral mucositis (mouth ulcers and lining breakdown), often dose-limiting in cancer patients. The ulcers usually start within the first one to two weeks of treatment and can be severe enough to require dose reduction or treatment breaks. Proactive dental optimization before starting everolimus is one of the standard preventive strategies.
Everolimus and dental care
Common questions patients have about Everolimus.
Related medications
Talk to us about your medications
Bring your medication list to your next visit.
We review every patient’s medications at every visit and adjust treatment planning when it matters. If you are starting a new medication or have a procedure coming up, mention it and we’ll walk through what to expect.